A novel surrogate index for hepatic insulin resistance.
OBJECTIVE
In epidemiological and genetic studies surrogate indices are needed to investigate insulin resistance in different insulin-sensitive tissues. Our objective was to develop a surrogate index for hepatic insulin resistance.


METHODS
A sample of 368 non-diabetic participants (age 43.0 ± 8.2 years, BMI 26.0 ± 4.0 kg/m(2); mean ± SD) whose endogenous glucose production (EGP) was measured with [6-6(2)H(2)]glucose in the fasting state and during the euglycaemic-hyperinsulinaemic clamp were included in the study. EGP multiplied by fasting plasma insulin (FPI) concentration was the reference measurement for liver insulin resistance (liver IR). Liver IR index was calculated with linear regression analysis including age, obesity indices, lipids, lipoproteins and several variables regulating glucose metabolism.


RESULTS
The following variables were significantly associated with liver IR in multiple forward stepwise regression analysis: insulin AUC in an OGTT, fat mass, HDL-cholesterol and BMI. Liver IR index correlated significantly with EGP×FPI (r = 0.65, p < 0.001). In participants with abnormal glucose tolerance, the correlation of liver IR with EGP×FPI was slightly stronger (r = 0.69, p < 0.001) than in those with normal glucose tolerance (r = 0.62, p < 0.001).


CONCLUSIONS
We generated a novel surrogate index for liver insulin resistance correlating strongly with EGP × FPI.
Department of Medicine, University of Eastern Finland, Kuopio University Hospital, 70210, Kuopio, Finland.
J
J
Vangipurapu
A
A
Stančáková
T
T
Kuulasmaa
J
J
Paananen
J
J
Kuusisto
E
E
Ferrannini
M
M
Laakso
D000328:Adult; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D005215:Fasting / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000502:physiology*; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged
D015415:Biomarkers; D007328:Insulin